Serial Number | 98029394 |
Word Mark | COMMENSE BIO |
Filing Date | Tuesday, June 6, 2023 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Thursday, September 12, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Pharmaceutical preparations and therapeutic agents and research and development for the prevention and treatment of infectious diseases, including those with antimicrobial resistance, and disorders, in the realms of dermal and mucosal diseases and disorders, gastrointestinal diseases and disorders, urological diseases and disorders, oral diseases and disorders, and respiratory diseases and disorders, for humans and animals |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, July 10, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Commense Bio, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Boulder, CO 80301 |
Event Date | Event Description |
Friday, June 9, 2023 | NEW APPLICATION ENTERED |
Monday, July 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, February 27, 2024 | ASSIGNED TO EXAMINER |
Thursday, September 12, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Thursday, September 12, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Wednesday, May 29, 2024 | NON-FINAL ACTION E-MAILED |
Wednesday, May 29, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, May 29, 2024 | NON-FINAL ACTION WRITTEN |